MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities$45,405,126 Cash and cashequivalents$32,659,770 Prepaid expenses andother current assets$941,883 Restricted cash$100,000 Total current assets$79,106,779 Goodwill$14,869,399 Deferred offering costs$50,978 Total assets$94,027,156 Accumulated deficit-$814,204,124 Total liabilities,redeemable preferred stock...$94,027,156 Total stockholders'deficit-$254,013,860 Additional paid-in capital$560,185,880 Common stock 0.0001 parvalue 250,000,000...$4,384 Total liabilities$343,079,094 Series a convertiblepreferred stock 0.0001 par...$4,961,922 Warrant liability$278,596,901 Liability related to thesale of future...$60,000,000 Total currentliabilities$4,482,193 Accrued expenses andother current...$2,363,968 Accounts payable$2,118,225
Balance Sheet

Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences, Inc. (NERV)

source: myfinsight.com